Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jitka A I Virag

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Sleep Medicine|February 14, 2015
Circadian rhythm complexities in cardiovascular dynamicsJitka A I Virag
Frontiers in Physiology|November 18, 2014
Circadian influences on myocardial infarctionJitka A I Virag, Robert M Lust
Pharmaceuticals (Basel, Switzerland)|June 5, 2020
Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic ApplicationsRobert M Hughes, Jitka A I Virag
Journal of Visualized Experiments : Jove|June 16, 2011
Coronary artery ligation and intramyocardial injection in a murine model of infarctionJitka A I Virag, Robert M Lust
The Journal of Physiology|February 2, 2011
Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in miceJessica L Dries, Susan D Kent, Jitka A I Virag
Frontiers in Pharmacology|June 10, 2025
Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changesSoroush Taherkhani, Mohammad Sheibani, Ali Mohammadkhanizadeh, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 20, 2018
Guidelines for measuring cardiac physiology in miceMerry L Lindsey, Zamaneh Kassiri, Jitka A I Virag, et al.
The American Journal of Pathology|September 18, 2007
Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular functionJitka A I Virag, Marsha L Rolle, Julia Reece, et al.
Frontiers in Physiology|May 6, 2014
Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathyWesley T O'Neal, William F Griffin, Susan D Kent, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2025
Matrix metalloproteinases and their association with preeclampsia/eclampsia with maternal age: A potential link to cardiovascular disease in later lifeSoroush Taherkhani, Mohammad Sheibani, Ronak Ahmadi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Sleep Medicine|February 14, 2015
Circadian rhythm complexities in cardiovascular dynamicsJitka A I Virag
Frontiers in Physiology|November 18, 2014
Circadian influences on myocardial infarctionJitka A I Virag, Robert M Lust
Pharmaceuticals (Basel, Switzerland)|June 5, 2020
Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic ApplicationsRobert M Hughes, Jitka A I Virag
Journal of Visualized Experiments : Jove|June 16, 2011
Coronary artery ligation and intramyocardial injection in a murine model of infarctionJitka A I Virag, Robert M Lust
The Journal of Physiology|February 2, 2011
Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in miceJessica L Dries, Susan D Kent, Jitka A I Virag
Frontiers in Pharmacology|June 10, 2025
Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changesSoroush Taherkhani, Mohammad Sheibani, Ali Mohammadkhanizadeh, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 20, 2018
Guidelines for measuring cardiac physiology in miceMerry L Lindsey, Zamaneh Kassiri, Jitka A I Virag, et al.
The American Journal of Pathology|September 18, 2007
Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular functionJitka A I Virag, Marsha L Rolle, Julia Reece, et al.
Frontiers in Physiology|May 6, 2014
Deletion of the EphA2 receptor exacerbates myocardial injury and the progression of ischemic cardiomyopathyWesley T O'Neal, William F Griffin, Susan D Kent, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 18, 2025
Matrix metalloproteinases and their association with preeclampsia/eclampsia with maternal age: A potential link to cardiovascular disease in later lifeSoroush Taherkhani, Mohammad Sheibani, Ronak Ahmadi, et al.
Pageof 2